Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation

JAAD Case Rep. 2021 Apr:10:63-68. doi: 10.1016/j.jdcr.2021.02.018. Epub 2021 Mar 2.
No abstract available

Keywords: ACE-I, angiotensin-converting enzyme inhibitor; ACE2, angiotensin-converting enzyme receptor; AngII, angiotensin II; COVID-19; DIR, delayed inflammatory reaction; RAS, renin-angiotensin system; SARS-CoV-2; angiotensin II; angiotensin-converting enzyme inhibitor; delayed inflammatory reaction; delayed inflammatory reaction (DIR); dermal filler; edema; hyaluronic acid; mRNA, messenger RNA.

Publication types

  • Case Reports